About M J Biopharm Private Limited
Data last updated:
M J Biopharm Private Limited was a private limited company based in Mumbai, Maharashtra, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 August 1987.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U29249MH1987PTC044458. Its GSTIN is 27AADCS9530P1ZP (Maharashtra). The company held 2 GST registrations, of which 1 is active.
The company had an authorised share capital of ₹20 Cr and a paid-up capital of ₹13.01 Cr. It was led by directors Amol Jashvant Shah (Managing Director) and Dhaval Vipin Vashi.
Its last annual general meeting (AGM) was held on 29 September 2017, and its latest financial statements are for the year ended 31 March 2017. The registered office was at 113 Jolly Maker Chambers 2 Nariman Point, Mumbai, Maharashtra, India – 400021.
As per the financials filed for FY 2017, the company reported a revenue of ₹119.1 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹7.78 Cr (net margin 6.5%) and EBITDA of ₹13.97 Cr (EBITDA margin 11.7%).
The company had about 264 employees on its provident fund (EPFO) records before it was dissolved. Its group structure included 1 subsidiary.
The company was associated with 1 brand: MJ-Biopharma. As per MCA filings, the company had satisfied charges of ₹89.62 Cr on record. Court records list 8 cases involving the company, including 5 filed by the company and 3 filed against it; 3 cases are pending.
The last known website on record is mjbiopharm.com.
Company details
Contact details
M J Biopharm Private Limited's registered office is in Mumbai, Maharashtra. Its website is mjbiopharm.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address113 Jolly Maker Chambers 2 Nariman Point, Mumbai, Maharashtra, India – 400021
- IndustryPharma, Drug Formulation & Development
To see the full contact details of M J Biopharm Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
M J Biopharm operates one associated brand: MJ-Biopharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Animal and human rDNA Insulin products and dosage forms | mjbiopharm.com |
Business activity
The main business activity of M J Biopharm is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of M J Biopharm Private Limited, buy the company report.
Financials of M J Biopharm Private Limited
FY 2017 filings availableM J Biopharm Private Limited reported revenue of ₹119.1 Cr (up 9% YoY) for FY 2017.
Compounded Annual Growth Rate (CAGR)
Revenue rose 9% in the latest year. EBITDA fell 24% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | ₹119.1 Cr | ||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹13.97 Cr | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹7.78 Cr | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 11.7% | ||
| Net Profit Margin | 6.5% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of M J Biopharm Private Limited, buy the company report.
Board of directors of M J Biopharm Private Limited
M J Biopharm has 2 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amol Jashvant Shah | Managing Director | 03 Dec 1997 | 28 Years 10 Months | As last reported |
| Dhaval Vipin Vashi Also directs: M. J. Biopharm Private Limited | Director | 22 Jun 2013 | 13 Years 4 Months | As last reported |
Peer comparison
M J Biopharm Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shine Pharmaceuticals Limited | ₹120.09 Cr (FY 2025) | -4.0% | Vadodara, Gujarat, India | |||
| Ananta Medicare Limited | ₹120.04 Cr (FY 2025) | 50.0% | Delhi, India | |||
| Amol Pharmaceuticals Private Limited | ₹119.9 Cr (FY 2025) | 5.0% | Jaipur, Rajasthan, India | |||
| Alvita Pharma Private Limited | ₹119.83 Cr (FY 2024) | 7.0% | Ahmedabad, Gujarat, India | |||
| M J Biopharm Private Limitedthis company | ₹119.1 Cr (FY 2017) | ₹7.78 Cr | 6.5% | 9.0% | 264 | Mumbai, Maharashtra, India |
| Pell Tech Health Care Private Limited | ₹118.72 Cr (FY 2025) | 16.0% | Thane, Maharashtra, India | |||
| Ronak Healthcare Private Limited | ₹118.43 Cr (FY 2025) | 79.0% | Vadodara, Gujarat, India | |||
| Zen Pharma Private Limited | ₹118.25 Cr (FY 2022) | 24.0% | Mumbai, Maharashtra, India | |||
| Anglo-French Drugs & Industries Limited | ₹117.99 Cr (FY 2025) | 18.0% | Mumbai, Maharashtra, India | |||
| Bioaltus Pharmaceuticals Private Limited | ₹117.77 Cr (FY 2025) | 26.0% | Thane, Maharashtra, India |
To see the full peer comparison of M J Biopharm Private Limited, buy the company report.
Auditor
M J Biopharm Private Limited is audited by DELOITE HASKINS & SELLS for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DELOITE HASKINS & SELLS | FY 2017 | 117366W |
Shareholding
The shareholding of M J Biopharm Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of M J Biopharm Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 Jan 2009 | 10137160 | Abn Amro Bank N. V. | ₹14.5 Cr | Satisfied | |
| 25 Jun 2007 | 10058726 | Abn Amro Bank N. V. | ₹18.5 Cr | Satisfied | |
| 17 Aug 2006 | 10014306 | Export-Import Bank of India | ₹5.5 Cr | Satisfied | |
| 28 May 2003 | 90213969 | Canara Bank | ₹35 Lakh | Satisfied | |
| 12 Mar 2001 | 90213682 | Canara Bank | ₹2.89 Lakh | Satisfied |
To see the full charge records of M J Biopharm Private Limited, buy the company report.
Total charge records: 10 View all charges
Legal cases
M J Biopharm Private Limited has 8 court cases on record: 5 filed by M J Biopharm, 3 filed against it. 3 cases are pending and 5 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 6 | 3 | 2 |
| High courts | 2 | 0 | 1 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Pune, Maharashtra | Civil suit | Filed against the company by an individual | Pending |
| District court, Maharashtra Industrial and Lab, Maharashtra | Court case (Complaint ULP) | Filed against the company by an individual | Pending |
| High Court, MAHARASHTRA | Writ petition | Filed by the company against Prin. Commissioner Ra and Ex Offcio and Ors | Pending |
| High Court, MAHARASHTRA | Interim or miscellaneous application | Filed by the company against Principal Commissioner Ra and Ex Officio and Ors | Disposed |
| District court, Pune, Maharashtra | Criminal miscellaneous application | Filed by the company against Institute of Biotechnology and Antibiotics and 5 others | Disposed |
To see the full case history of M J Biopharm Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for M J Biopharm Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
M J Biopharm has 1 subsidiary company. This group structure data is as of FY 2017. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Marvel Life Sciences Private Limited | U24230MH1999PTC119044 |
To see the full group structure of M J Biopharm Private Limited, buy the company report.
Employees & EPFO
M J Biopharm Private Limited has a workforce of 264 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
GST
M J Biopharm has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCS9530P1ZP | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of M J Biopharm Private Limited, buy the company report.
Recent activity
M J Biopharm Private Limited has 9 board changes on record since 1997: 2 appointments and 7 cessations. The latest: Shekhar Keshav Mandrekar ceased to be Alternate Director on 23 Jan 2017.
22 earlier events are in the company report.
Frequently asked questions
M J Biopharm has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
M J Biopharm was a private limited company based in Mumbai, Maharashtra, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 24 August 1987 and is registered under CIN U29249MH1987PTC044458. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
M J Biopharm was incorporated on 24 August 1987. It is registered with the Registrar of Companies, Mumbai.
M J Biopharm had 2 directors:
- Amol Jashvant Shah - Managing Director
- Dhaval Vipin Vashi - Director
The CIN (Corporate Identification Number) of M J Biopharm is U29249MH1987PTC044458. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of M J Biopharm is at 113 Jolly Maker Chambers 2 Nariman Point, Mumbai, Maharashtra, India – 400021.
M J Biopharm can be reached through the website mjbiopharm.com. Its registered office is in Mumbai, Maharashtra, India.
The latest financial statements of M J Biopharm on record with the MCA are for the year ended 31 March 2017. Its last annual general meeting was held on 29 September 2017. Year-wise statements from 2015 are in the company report.
The GSTIN of M J Biopharm is 27AADCS9530P1ZP, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
M J Biopharm operated in the pharma industry, in the drug formulation and development segment.
The peers of M J Biopharm by revenue are Shine Pharmaceuticals Limited, Ananta Medicare Limited, Amol Pharmaceuticals Private Limited, Alvita Pharma Private Limited, Pell Tech Health Care Private Limited and 4 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).